Sergey Didenko / Shutterstock.com
Gender-based Violence
Gender-based violence (GBV) affects one in three women worldwide, making it an urgent and important policy challenge. Using its global platform, the Wilson Center is convening discussions not only on the ongoing crisis of GBV—made worse by the global COVID-19 pandemic—but also on the programs and policies that are beginning to make a difference.
Project
Accessing Justice: Gender-Based Violence and the Rule of Law
In recognition of the need to explore more fully the connections between laws, policies and the persistence of gender-based violence, the Wilson Center launched the project "Accessing Justice" to examine gender-based violence from a rule of law lens.
Learn more
16 Days of Activism against Gender-based Violence
In 2020, in parallel with the UN campaign "16 Days of Activism against Gender-Based Violence, the Wilson Center hosted a series of events, publications, and podcasts to facilitate dialogue and understanding, not only of the ongoing crisis of GBV worldwide – made worse by the global pandemic, but also of the programs and policies that are beginning to make a difference.
Interview Series: Bipartisan Approaches to Ending Gender-Based Violence
The Wilson Center is proud to announce our newest interview series with members of the U.S. Congress, where we discuss ways in which Congress can further awareness, dialogue, and policy action to protect women from violence—including the Violence Against Women Act.
Insight & Analysis
Featured Experts
Sarah B. Barnes
Director, Maternal Health Initiative
Merissa Khurma
Director, Middle East Program
Beatriz García Nice
Associate / GBV Project Lead
Margot Badran
Global Fellow
What is Gender-Based Violence?
Gender-based violence is a global pandemic that impacts the lives of one in three women worldwide. Domestic violence is the most common type of GBV, impacting one in four women. But violence takes many forms.
Lean moreLearn more about gender-based violence.
Subscribe for updates about new events, articles, videos, and more.